FDA approves first drug for treatment of peanut allergy for children
Treatment with this product may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older.
from FDA Press Releases RSS Feed https://ift.tt/2uUSJLe
via IFTTT
No comments:
Post a Comment